Advances in Existing Drugs and Personalized Therapy Could Help Treat Osteoarthritis

Advances in Existing Drugs and Personalized Therapy Could Help Treat Osteoarthritis

A recent study could help repurpose existing drugs, develop new medicines targeted to broad disease processes, and eventually lead to a personalized approach.

Allegro confirms successful safety testing of osteoarthritis treatment - Pharmafile

Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment for osteoarthritis. This was announced at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO) in Rome, Italy. The product, known as microparticle hydrogel hydrocelin, was announced as being non-pyrogenic following a series of […] The post Allegro co…

From Raw RNA-Seq Data to Insights: Finding Therapeutic Targets for Osteoarthritis

USE CASE From Raw Data to Therapeutic Insights: End-to-End RNA-Seq Analysis of IL-17A in Osteoarthritis Written by Axel Martinelli in collaboration with Almaden Genomics. Introduction In 2021 Mimpen et al. ... The post IL-17A as a possible therapeutic target for Osteoarthritis appeared first on BigOmics Analytics.